Cyfuse Biomedical K.K.

Cyfuse Biomedical K.K.Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K.

Cyfuse Biomedical K.K.

Developing 3D bioprinting technology for regenerative medicine.

Website
DR 0.12010ActiveOsaka, Japan
Rate
Advertise here

About

Cyfuse Biomedical K.K. is a Japanese startup specializing in regenerative medicine and drug discovery. They have developed a proprietary "Bio 3D Printing" technology that creates three-dimensional tissues and organs solely from cells, without the need for artificial scaffolds. Their technology, which utilizes a "Kenzan method" of stacking cell spheroids, is applied to their Bio 3D printers (Regenova® and S-PIKE®) and the development of regenerative medical products for tissue and organ repair, as well as drug discovery screening tools.
Frequently asked

What does Cyfuse Biomedical K.K. do?

Cyfuse Biomedical K.K. is a Japanese startup specializing in regenerative medicine and drug discovery. They have developed a proprietary "Bio 3D Printing" technology that creates three-dimensional tissues and organs solely from cells, without the need for artificial scaffolds. Their technology, which utilizes a "Kenzan method" of stacking cell spheroids, is applied to their Bio 3D printers (Regenova® and S-PIKE®) and the development of regenerative medical products for tissue and organ repair, a…

What is Cyfuse Biomedical K.K.'s valuation?

StartupHub estimates Cyfuse Biomedical K.K.'s effective valuation at $2.1B (range $1.4B to $3.2B, 10% confidence), based on comparable companies in the sector.

How much funding has Cyfuse Biomedical K.K. raised?

Cyfuse Biomedical K.K. has raised a total of $540M in funding. The most recent round on record is Series A.

Where is Cyfuse Biomedical K.K. headquartered?

Cyfuse Biomedical K.K. is headquartered in Osaka, Japan.

When was Cyfuse Biomedical K.K. founded?

Cyfuse Biomedical K.K. was founded in 2010.

Comments

No comments yet. Be the first to share your take.